ATE20886T1 - Diaminothiazol-1-oxyde und -1,1-dioxyde zum inhibieren der magensekretion. - Google Patents
Diaminothiazol-1-oxyde und -1,1-dioxyde zum inhibieren der magensekretion.Info
- Publication number
- ATE20886T1 ATE20886T1 AT82105169T AT82105169T ATE20886T1 AT E20886 T1 ATE20886 T1 AT E20886T1 AT 82105169 T AT82105169 T AT 82105169T AT 82105169 T AT82105169 T AT 82105169T AT E20886 T1 ATE20886 T1 AT E20886T1
- Authority
- AT
- Austria
- Prior art keywords
- loweralkyl
- membered heterocycle
- hydrogen
- gastrogenic
- diaminothiazole
- Prior art date
Links
- 230000002401 inhibitory effect Effects 0.000 title 1
- 230000028327 secretion Effects 0.000 title 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 125000005605 benzo group Chemical group 0.000 abstract 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 239000011593 sulfur Chemical group 0.000 abstract 2
- JULGETMCAHYYJO-UHFFFAOYSA-N 1-oxo-1,2-thiazole-3,4-diamine Chemical class NC1=CS(=O)N=C1N JULGETMCAHYYJO-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 230000027119 gastric acid secretion Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 229910052757 nitrogen Chemical group 0.000 abstract 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1896—Compounds having one or more Si-O-acyl linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Paints Or Removers (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27369281A | 1981-06-15 | 1981-06-15 | |
| EP82105169A EP0067436B1 (de) | 1981-06-15 | 1982-06-14 | Diaminothiazol-1-Oxyde und -1,1-Dioxyde zum Inhibieren der Magensekretion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE20886T1 true ATE20886T1 (de) | 1986-08-15 |
Family
ID=23045011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT82105169T ATE20886T1 (de) | 1981-06-15 | 1982-06-14 | Diaminothiazol-1-oxyde und -1,1-dioxyde zum inhibieren der magensekretion. |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0067436B1 (de) |
| JP (1) | JPS5838275A (de) |
| AT (1) | ATE20886T1 (de) |
| AU (1) | AU553045B2 (de) |
| DE (1) | DE3272132D1 (de) |
| DK (1) | DK266182A (de) |
| ES (1) | ES513090A0 (de) |
| GR (1) | GR76149B (de) |
| IE (1) | IE53068B1 (de) |
| NZ (1) | NZ200892A (de) |
| PT (1) | PT75048B (de) |
| ZA (1) | ZA824121B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR77847B (de) * | 1981-12-14 | 1984-09-25 | American Home Prod | |
| EP0105732A3 (de) * | 1982-10-01 | 1985-09-04 | Beecham Group Plc | Histamin-H2-rezeptoren-Antagonisten der Benzisothiazolamino- und Benzothiadiazinamino Reihe |
| US4590192A (en) * | 1982-10-01 | 1986-05-20 | Beecham Group P.L.C. | Benzisothiazoles, their pharmaceutical compositions, and method of use |
| US4567191A (en) * | 1983-06-07 | 1986-01-28 | Merck & Co., Inc. | Amino-phenyl-thiadiazoledioxides as gastric secretion inhibitors |
| DE3438073A1 (de) * | 1984-10-17 | 1986-04-24 | Ludwig Heumann & Co GmbH, 8500 Nürnberg | Butenylderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US4578473A (en) * | 1985-04-15 | 1986-03-25 | Warner-Lambert Company | Process for quinoline-3-carboxylic acid antibacterial agents |
| ES2321186T3 (es) | 2002-10-09 | 2009-06-03 | Schering Corporation | Dioxidos de tiadiazol y monoxidos de tiadiazol como ligandos de los receptores de quimioquinas cxc y cc. |
| MY139808A (en) | 2003-12-19 | 2009-10-30 | Schering Corp | Thiadiazoles as cxc-and cc-chemokine receptor ligands |
| JP4851943B2 (ja) * | 2003-12-22 | 2012-01-11 | シェーリング コーポレイション | Ｃｘｃ−ケモカインレセプターリガンドおよびｃｃ−ケモカインレセプターリガンドとしてのイソチアゾールジオキシド |
| SE0500055D0 (sv) * | 2005-01-10 | 2005-01-10 | Astrazeneca Ab | Therapeutic agents 3 |
| TW200716576A (en) | 2005-06-07 | 2007-05-01 | Shionogi & Co | Heterocyclic derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| CN101253165A (zh) | 2005-06-29 | 2008-08-27 | 先灵公司 | 作为cxc－化学活素受体配体的二取代的二唑 |
| ATE486078T1 (de) | 2005-06-29 | 2010-11-15 | Schering Corp | 5,6-disubstituierte oxadiazolopyrazine und thiadiazolopyrazine als liganden des cxc- chemokinrezeptors |
| JP5240775B2 (ja) | 2006-03-30 | 2013-07-17 | 塩野義製薬株式会社 | Ｉ型１１βヒドロキシステロイド脱水素酵素阻害活性を有するイソキサゾール誘導体およびイソチアゾール誘導体 |
| US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1338169A (en) * | 1971-03-09 | 1973-11-21 | Smith Kline French Lab | Ureas thioureas and guanidines |
| GB1419994A (en) * | 1973-05-03 | 1976-01-07 | Smith Kline French Lab | Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them |
| GB1496787A (en) * | 1974-03-12 | 1978-01-05 | Smith Kline French Lab | Heteroalkylthioalkyl amidine derivatives |
| US4005205A (en) * | 1974-04-24 | 1977-01-25 | Smith Kline & French Laboratories Limited | Compositions and methods for inhibiting H2 histamine receptors |
| IN146736B (de) * | 1975-10-02 | 1979-08-25 | Smith Kline French Lab | |
| US4145546A (en) * | 1975-10-02 | 1979-03-20 | Smith Kline & French Laboratories Limited | 4-Pyrimidone compounds |
| US4154834A (en) * | 1975-12-29 | 1979-05-15 | Smith Kline & French Laboratories Limited | Substituted isocytosines having histamine H2 -antagonist activity |
| MW5076A1 (en) * | 1975-12-29 | 1978-02-08 | Smith Kline French Lab | Pharmacologicalle active compounds |
| US4216318A (en) * | 1975-12-29 | 1980-08-05 | Smith Kline & French Laboratories Limited | Heterocyclic alkyl 4-pyrimidones |
| NZ186511A (en) * | 1977-03-19 | 1980-11-14 | Smith Kline French Lab | 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones |
| GB1604674A (en) * | 1977-05-17 | 1981-12-16 | Allen & Hanburys Ltd | Aminoalkyl-benzene derivatives |
| IE46886B1 (en) * | 1977-05-17 | 1983-10-19 | Allen & Hanburys Ltd | Aminoalkyl-benzene derivatives |
| ZA783118B (en) * | 1977-06-02 | 1979-06-27 | Smith Kline French Lab | Amidines |
| US4210658A (en) * | 1977-09-08 | 1980-07-01 | Smith Kline & French Laboratories Limited | Amidinosulphonic acid derivatives |
| GB2023133B (en) * | 1978-04-26 | 1982-09-08 | Glaxo Group Ltd | Heterocyclic derivatives |
| AR228941A1 (es) * | 1978-04-26 | 1983-05-13 | Glaxo Group Ltd | Procedimiento para preparar nuevos derivados de 3,5-diamino-1,2,4-triazol que son activos contra receptores histaminicos |
| IL57416A (en) * | 1978-05-30 | 1983-03-31 | Smith Kline French Lab | Nitro compounds,processes for preparing them and compositions containing them |
| NL182032C (nl) * | 1978-06-05 | 1987-12-16 | Philips Nv | Inrichting voor het centreren, richten en vastklemmen van een roterende plaat. |
| US4374836A (en) * | 1978-10-16 | 1983-02-22 | Imperial Chemical Industries Ltd. | Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them |
| US4255428A (en) * | 1979-03-24 | 1981-03-10 | Smith Kline & French Laboratories Limited | 5-(Hydroxypyridylalkyl)-4-pyrimidones |
| JPS55145683A (en) * | 1979-04-26 | 1980-11-13 | Smith Kline French Lab | Pyrimidone derivative |
| FI76795C (fi) * | 1979-09-04 | 1988-12-12 | Bristol Myers Co | Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 3,4-disubstituerade 1,2,5-tiadiazol-1-oxider och -1,1-dioxider samt nya mellanprodukter. |
| IL61233A (en) * | 1979-10-24 | 1984-08-31 | Smith Kline French Lab | Guanidino thiazolylalkylamino(alkylthioalkylamino)nitro pyrroles,process for their preparation and pharmaceutical compositions containing them |
| GR71929B (de) * | 1979-11-13 | 1983-08-19 | Ici Ltd |
-
1982
- 1982-06-08 IE IE1360/82A patent/IE53068B1/en unknown
- 1982-06-09 NZ NZ200892A patent/NZ200892A/en unknown
- 1982-06-10 AU AU84761/82A patent/AU553045B2/en not_active Ceased
- 1982-06-11 ZA ZA824121A patent/ZA824121B/xx unknown
- 1982-06-14 AT AT82105169T patent/ATE20886T1/de not_active IP Right Cessation
- 1982-06-14 GR GR68436A patent/GR76149B/el unknown
- 1982-06-14 EP EP82105169A patent/EP0067436B1/de not_active Expired
- 1982-06-14 DE DE8282105169T patent/DE3272132D1/de not_active Expired
- 1982-06-14 DK DK266182A patent/DK266182A/da not_active Application Discontinuation
- 1982-06-14 PT PT75048A patent/PT75048B/pt unknown
- 1982-06-14 ES ES513090A patent/ES513090A0/es active Granted
- 1982-06-15 JP JP57102911A patent/JPS5838275A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PT75048A (en) | 1982-07-01 |
| ES8307774A1 (es) | 1983-08-01 |
| GR76149B (de) | 1984-08-03 |
| IE53068B1 (en) | 1988-05-25 |
| ES513090A0 (es) | 1983-08-01 |
| EP0067436B1 (de) | 1986-07-23 |
| DE3272132D1 (en) | 1986-08-28 |
| ZA824121B (en) | 1984-01-25 |
| AU8476182A (en) | 1982-12-23 |
| EP0067436A2 (de) | 1982-12-22 |
| AU553045B2 (en) | 1986-07-03 |
| IE821360L (en) | 1982-12-15 |
| DK266182A (da) | 1982-12-16 |
| JPS5838275A (ja) | 1983-03-05 |
| EP0067436A3 (en) | 1983-01-19 |
| NZ200892A (en) | 1986-04-11 |
| PT75048B (en) | 1985-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE20886T1 (de) | Diaminothiazol-1-oxyde und -1,1-dioxyde zum inhibieren der magensekretion. | |
| NO174049C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 5-lipoksygenase-inhiberende 4-(4-fenyl-1-piperazinyl)fenoler | |
| HUT56099A (en) | Process for producing 2-(2-amino-thiazol-4-yl)-2-(4-pyridon-2-yl-methoxy-imino)-acetic acid derivatives | |
| JPS55164678A (en) | Novel cyclic imidazolecyanoguanidine | |
| DK519985D0 (da) | Quinoloncarboxylsyrederivater, fremgangsmaade til fremstilling deraf og antibakterielt middel indeholdende saadanne derivater | |
| PL294221A1 (en) | Method of obtaining novel 1-pyrido (3,4-b)-1,4-oxazinyl-4-ilo)-1h-indoles | |
| ES8604543A1 (es) | Procedimiento para la obtencion de derivados piperazinicos | |
| ES8801639A1 (es) | Procedimiento para la obtencion de derivados del acido barbiturico | |
| ATE19880T1 (de) | Thiadiazole oxyde mit antisekretorischer wirkung. | |
| RO86084B (ro) | Procedeu pentru prepararea unor derivati ai 6, 6-dioxidului de oxazinobenzatiazina | |
| NO911998L (no) | Pyrido(3,4-b)(pyrrolo(1,2-e)(1,4,5)oksadiazepin og beslektede analoger og fremgangsmaate for fremstilling derav. | |
| NZ215439A (en) | Benzo(c) 1,5 naphthyridines and pharmaceutical compositions | |
| HU9600597D0 (en) | 4-alkylthio-pyrimidin-5-yl acetic acid derivates and fungicidal compositions containing them as an active ingredient | |
| DE3464915D1 (en) | (5-(2-aminomethyl-imidazol-1-yl)-1,3-dialkyl-1h-pyrazol-4-yl)(aryl)methanones and processes for their production | |
| HUT34316A (en) | Process for producing heterocyclic hydroximidates and thiohydroximidates and their carbamate-ester derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |